Purchase Order HHSD2002015M63119P
- Not listed
- This is a $114,707.80 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for the provision of laboratory supplies. The contract has no set-aside designation. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics and laboratory equipment, has a history of providing critical care analyzers, reagents, test kits, and associated supplies and services to various federal agencies, including the...
- This $139,966.72 firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the provision of reagent testing supplies and does not have a set-aside designation. Roche Diagnostics has previously received awards from various federal agencies, including the Department of...
- This is a $144,721.10 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for laboratory supplies. The contract has no set-aside designation. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. Roche has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and...
- This federal contract award with ID HHSD2002017M92821P was made by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $99,695.80 firm fixed price purchase order is for Roche lab equipment and supplies, with a completion date of January 27, 2017. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and other...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract has a ceiling value of $75,000.00 and was awarded on December 5, 2016 with a completion date of November 12, 2020. The award does not have a set-aside designation. Roche Diagnostics has provided critical care analyzers,...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, laboratory instruments, and associated products and services. The $113,563 contract provides ICF laboratory equipment and maintenance for the CDC's Pittsburgh location. This award is not designated as a set-aside. Roche Diagnostics has received numerous federal contract awards from agencies including the Department...
- This is a firm fixed-price delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for preventative maintenance services on Roche's ROCEH diagnostic clinical analyzers. The $197,652.60 contract has an ultimate completion date of March 31, 2023 and is not set aside. Roche Diagnostics is a global in vitro diagnostics manufacturer that has received numerous federal contract awards across...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call award from the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, for $242,400.00 in laboratory supplies, linear array genotyping, and detection kits. The award has an ultimate completion date of April 27, 2017. Roche Diagnostics is a for-profit, foreign-owned manufacturer that has received numerous federal contract awards, including from the...
- This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency, to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The award, valued at $29,600.00, is for the supply of ROCHE COBAS 5800 REAGENTS under a firm fixed-price purchase order. The contract has an ultimate completion date of June 1, 2024. Roche Diagnostics...
- This is a $97,000.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the acquisition of MAGNA PURE EQUIPMENT and does not have a set-aside designation. Roche Diagnostics has received multiple prime contract and subcontract awards from various federal agencies to provide...
This is a federal contract award by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, for a service agreement to provide laboratory instruments. The fixed-price purchase order has a ceiling value of $79,756.08 and an ultimate completion date of September 3, 2020. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment, has previously received awards from various federal agencies including the Department of Veterans Affairs, Department of Defense, and Department of Health and Human Services. This contract is not set aside and is part of Roche's existing General Services Administration (GSA) Schedule contracts for laboratory instruments, equipment, and supplies. Roche also holds Indefinite Delivery Contracts and Blanket Purchase Agreements with federal agencies to provide ongoing access to essential medical equipment and consumables.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 4 | Exercise an Option | $17.5k | 2/21/19 | |
| 3 | Exercise an Option | $16.7k | 9/21/18 | |
| 2 | Exercise an Option | $15.9k | 3/31/17 | |
| 1 | Exercise an Option | $15.2k | 8/11/16 | |
| Not listed | Not listed | $14.4k | 6/26/15 |